BCAL Diagnostics Limited (ASX:BDX)
Australia
· Delayed Price · Currency is AUD 0.0870
+0.0030 (3.57%)
Apr 28, 2025, 4:10 PM AEST
BCAL Diagnostics Company Description
BCAL Diagnostics Limited, a screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer.
It develops BREASTEST, a laboratory developed test or in-house in vitro diagnostic blood test. The company was incorporated in 2010 and is headquartered in Sydney, Australia.
BCAL Diagnostics Limited
| Country | Australia |
| Founded | 2010 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| CEO | Shane Ryan |
Contact Details
Address: 50 Clarence Street Sydney, 2000 Australia | |
| Phone | 61 2 9078 7671 |
| Website | bcaldiagnostics.com |
Stock Details
| Ticker Symbol | BDX |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000160921 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Shane Ryan M.B.A. | Chief Executive Officer |
| Jayne Andrea Shaw | Co-Founder and Executive Chairman |
| Hon. Ronald Anthony Phillips A.O. | Co-Founder and Non-Executive Director |
| Guy Adrian Robertson B.Com., B.Comm(Hons.), CA, MAICD | Chief Financial Officer and Company Secretary |
| Sean Kennedy | Director of Corporate Finance |
| Tanya Thomas | Director of Investor Relations and Communications |
| Alexandra Feetham | Head of Innovation |
| Rebecca Shaw | Head of Webpage Development |